| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/22/2004 | WO2004032615A1 Chimeric mouse with regulated bradeion gene expression |
| 04/22/2004 | WO2004032614A2 Animal with modification of cytoplasmic dynein heavy chain 1 gene |
| 04/22/2004 | WO2004032599A2 Novel immunogenic proteins of leptospira |
| 04/22/2004 | WO2004027068A3 Systems for expressing toxic proteins, vectors and method of producing toxic proteins |
| 04/22/2004 | WO2004027056A3 Methods of use for thermostable rna ligases |
| 04/22/2004 | WO2004024933A3 Method for zymotic production of fine chemicals (mety) containing sulphur |
| 04/22/2004 | WO2004024932A3 Method for zymotic production of fine chemicals (meta) containing sulphur |
| 04/22/2004 | WO2004024931A3 Method for the production by fermentation of sulphur-containing fine chemicals (metf) |
| 04/22/2004 | WO2004024928A3 Transformed plants with enhanced prenylquinone biosynthesis |
| 04/22/2004 | WO2004024926A3 Transgenic expression cassettes for expressing nucleic acid sequences in sink tissues of plants that store carbohydrate |
| 04/22/2004 | WO2004020645A3 Chromosomal loci for the stringent control of gene activities via transcription activation systems |
| 04/22/2004 | WO2004020639A3 Production of multimeric fusion proteins using a c4bp scaffold |
| 04/22/2004 | WO2004020603A3 Analyte detection |
| 04/22/2004 | WO2004018687A3 Nucleic acid sequences encoding proteins associated with abiotic stress response |
| 04/22/2004 | WO2004018506A3 Inducible alphaviral/orip based gene expression system |
| 04/22/2004 | WO2004016649A3 Method for the production of an artificial polypeptide and artificial proteins produced by said method |
| 04/22/2004 | WO2004015395A3 Method for identifying mhc-presented peptide epitopes for t cells |
| 04/22/2004 | WO2004011592A3 Petal-array support for use with microplates |
| 04/22/2004 | WO2004007720A3 Treatment of proliferative disorders |
| 04/22/2004 | WO2004005544A3 Marker genes for determining renal toxicity |
| 04/22/2004 | WO2004003201A3 Antisense modulation of lrh1 expression |
| 04/22/2004 | WO2004003194A3 Protein glycosylation modification in pichia pastoris |
| 04/22/2004 | WO2004001013A3 Inhibition of gene expression in vertebrates using double-stranded rna (rnai) |
| 04/22/2004 | WO2003103571A3 Flavivirus vaccines |
| 04/22/2004 | WO2003097879A3 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc |
| 04/22/2004 | WO2003097680A3 Anti-bacterial peptides, genes coding for peptides, transformed organisms, vectors, preparation thereof and compositions containing same |
| 04/22/2004 | WO2003097673B1 Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide,virus-like particles prepared therefrom and a method for preparing the particles. |
| 04/22/2004 | WO2003095635A3 Nucleotide sequence coding for a mannitol 2-dehydrogenase and method for the production of d-mannitol |
| 04/22/2004 | WO2003089452A3 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase |
| 04/22/2004 | WO2003088812A3 Nor-1 and nur77 nuclear receptors as targets for anti-leukemia therapy |
| 04/22/2004 | WO2003087318A9 Truncated 24 kda basic fibroblast growth factor |
| 04/22/2004 | WO2003072014B1 Minicell compositions and methods |
| 04/22/2004 | WO2003070965A8 The eaat2 promoter and uses thereof |
| 04/22/2004 | WO2003068798A3 Oligonucleotide analogues and methods of use for modulating gene expression |
| 04/22/2004 | WO2003064625A3 Oligonucleotide compositions with enhanced efficiency |
| 04/22/2004 | WO2003062471A9 Model cell systems for screening of anti-hypertrophic therapeutics |
| 04/22/2004 | WO2003060084A9 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 04/22/2004 | WO2003060066A8 Nucleic acid delivery and expression |
| 04/22/2004 | WO2003057916A3 Cancer profiles |
| 04/22/2004 | WO2003057164A3 Compounds for delivering substances into cells |
| 04/22/2004 | WO2003055994A9 Hxhv virus, nucleic material, peptide material and uses |
| 04/22/2004 | WO2003046506A3 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies |
| 04/22/2004 | WO2003043587A3 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 04/22/2004 | WO2003040345A3 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/22/2004 | WO2003039346A8 Diagnostics and therapeutics for ocular abnormalities |
| 04/22/2004 | WO2003038130A8 Therapeutics and diagnostics for disorders of erythropoiesis |
| 04/22/2004 | WO2003033738A3 Polymorphic marker that can be used to assess the efficacy of interferon therapy |
| 04/22/2004 | WO2003027248A8 Antibody inhibitors of gdf-8 and uses thereof |
| 04/22/2004 | WO2003022202A9 Compositions and methods for treatment of cancer |
| 04/22/2004 | WO2003020893A3 New adenovirus type 7 vectors |
| 04/22/2004 | WO2003020763A9 Soluble t cell receptor |
| 04/22/2004 | WO2003014311A3 Methods for altering polyketide synthase genes |
| 04/22/2004 | WO2003012103A3 Nucleic acids coding for novel fbox proteins, their diagnostic and therapeutic uses |
| 04/22/2004 | WO2003004659A8 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 04/22/2004 | WO2002102846A3 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 04/22/2004 | WO2002098362A3 Use of rank antagonists to treat cancer |
| 04/22/2004 | WO2002094852A8 Taci-immunoglobulin fusion proteins |
| 04/22/2004 | WO2002092782A3 Diagnosis and treatment of malignant neoplasms |
| 04/22/2004 | WO2002092017A8 Human antipneumococcal antibodies from non-human animals |
| 04/22/2004 | WO2002090567A3 Sperm-specific cation channel, and uses therefor |
| 04/22/2004 | WO2002090300A8 Nucleic acids and proteins with thioredoxin reductase activity |
| 04/22/2004 | WO2002086163A8 Methods for high throughput genome analysis using restriction site tagged microarrays |
| 04/22/2004 | WO2002081658A8 Transgenic mice containing cacnb4 calcium ion channel gene disruptions |
| 04/22/2004 | WO2002081516A8 Narc10 and narc16, programmed cell death-associated molecules and uses thereof |
| 04/22/2004 | WO2002064731A9 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/22/2004 | WO2002063009A8 Lp mammalian proteins; related reagents |
| 04/22/2004 | WO1991007986A8 Method of treating septic shock |
| 04/22/2004 | WO1990013281A3 Method of suppressing hiv infection |
| 04/22/2004 | US20040078852 DNA encoding a binding protein of an ap2 domain amino acid sequence; enhancing the drought and cold tolerance of recombinant plants |
| 04/22/2004 | US20040078851 Production of human growth factors in monocot seeds |
| 04/22/2004 | US20040078850 Nucleotide sequence encoding a polypeptide that has functional zinc finger domains; alter the metabolic state of the transformed plants and plant cells |
| 04/22/2004 | US20040078849 Modulating developmental transitions in plants |
| 04/22/2004 | US20040078848 Expression of trehalose 6-phosphate synthase and trehalose 6-phosphate phosphatase in plant[[s]] plastids |
| 04/22/2004 | US20040078847 Method of enhancing entomophilous |
| 04/22/2004 | US20040078845 Production of gamma linolenic acid by a delta 6-desaturase |
| 04/22/2004 | US20040078844 DNA vector of a transfer nucleotide sequence of a plant active promoter linked to a recombinant tobacco rattle virus and border sequences that permit the transfer into a plant cell genome |
| 04/22/2004 | US20040078843 Method for controlling harmful organisms in the culture of useful plants |
| 04/22/2004 | US20040078842 Protein with endo-chitinase activity |
| 04/22/2004 | US20040078841 Root specific promoters |
| 04/22/2004 | US20040078840 Chimeric isoprenoid synthases and uses thereof |
| 04/22/2004 | US20040078839 Methods for modulating water-use efficiency or productivity in a plant |
| 04/22/2004 | US20040078838 Transgenic plant cells with reduced citrate synthase activity in comparison to wild type cells |
| 04/22/2004 | US20040078837 Four human zinc-finger-containing proteins: MDZ3, MDZ4, MDZ7 and MDZ12 |
| 04/22/2004 | US20040078836 Diacylglycerol O-Acyltransferase |
| 04/22/2004 | US20040078835 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 04/22/2004 | US20040078834 Transgenic animal whose genome has a transcriptional regulatory sequence capable of directing expression to b-cells linked to a dna sequence encoding t-cell leukemias |
| 04/22/2004 | US20040078833 Mutations in and genomic structure of herg - along QT syndrome gene |
| 04/22/2004 | US20040077847 Nucleic acid encoding a pneumoccocal surface protein c gene or epitope |
| 04/22/2004 | US20040077842 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 04/22/2004 | US20040077840 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroups B epitopes |
| 04/22/2004 | US20040077837 Microtubule-associated proteins and tubulins |
| 04/22/2004 | US20040077833 Regulation of human mrp5-like protein |
| 04/22/2004 | US20040077828 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 04/22/2004 | US20040077613 Stimulation of preadipocyte differentiation; insulin resis-tance syndrome, dyslipidemia, type 2 diabetes; LXR alpha receptor agonists |
| 04/22/2004 | US20040077583 Antisense modulation of BCL2-associated X protein expression |
| 04/22/2004 | US20040077582 Cationic reagents for transfection |
| 04/22/2004 | US20040077580 Phosphatidylinositol 3-kinase (PI3K) inhibitors; hyperpro-liferative disorders, metabolic disease, diabetes, type 2 diabetes, obesity |
| 04/22/2004 | US20040077579 Pharmaceutical compositions for the prevention and treatment of atherosclerosis and restenosis after PTCA |
| 04/22/2004 | US20040077578 Inhibition; hybridizing mRNA target; cancer |
| 04/22/2004 | US20040077577 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes |